Extensively drug resistant tuberculosis in Ivory Coast

Revue de pneumologie clinique
A S BakayokoE Aka-Danguy

Abstract

The emergence of tuberculosis with ultraresistant bacilli (TB-UR or XDR-TB) came to increase the threat concerning the progress realized in tuberculosis control. This observation establishes the only case of XDR-TB documented and published since the beginning of pharmacoresistant tuberculosis management in Ivory Coast from 2000 till 2010. This case was diagnosed in 2005 at a HIV-negative 32-year-old woman, initially declared MDR-TB. Looking forward to a treatment of category IV, she was treated by therapeutic truncated protocols recombining antituberculous molecules to which the patient was still sensitive. This treatment (PAS, cycloserin, ciprofoxacin, ethionamid, ethambutol and kanamycin) was introduced after 9 months of waiting and was completely led in ambulatory under the supervision of a member of the family. The diagnosis of XDR-TB concerned new tests of sensibility spread to second line antituberculous drugs in front of the absence of spits negativation at the end of 14 months of a second line treatment marked by frequent stock shortages. The death arose at M19 of treatment by chronic heart pulmonary. XDR-TB remains dark prognosis and is almost synonymic of "death sentence" in our countries with limited resources. The a...Continue Reading

References

Apr 9, 2008·Médecine et maladies infectieuses·A K TanonA Kadio
Aug 9, 2008·The New England Journal of Medicine·Carole D MitnickMercedes C Becerra
Oct 17, 2009·American Journal of Respiratory and Critical Care Medicine·Neel R GandhiUNKNOWN Tugela Ferry Care and Research (TF CARES) Collaboration
Apr 23, 2010·Emerging Infectious Diseases·Nuccia SaleriAlberto Matteelli
Mar 12, 2011·Emerging Infectious Diseases·N Sarita ShahNeel R Gandhi

❮ Previous
Next ❯

Citations

Nov 8, 2017·BMC Research Notes·Bassirou DiarraSouleymane Diallo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.